838 Clinical features of superior vena cava syndrome complicated with primary lung cancer; Role of magnetic resonance imaging

Lung Cancer ◽  
1997 ◽  
Vol 18 ◽  
pp. 216
Author(s):  
M. Bando ◽  
Y. Ishii ◽  
S. Kitamura
Diagnostics ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 2058
Author(s):  
Liliana Dragomir ◽  
Virginia Marina ◽  
Mihaela Anghele ◽  
Aurelian-Dumitrache Anghele

Most cases of superior vena cava syndrome are easily diagnosed bya clinical examination alone, but several diagnostic tests and procedures can be helpful. When a patient presentswith a suspected diagnosis of superior vena cava syndrome, the first step is to obtain an imaging study that confirms the diagnosis and aids treatment decisions. Magnetic resonance imaging, contrast-enhanced CT scanning, radionuclide flow studies and traditional venography are all appropriate techniques. Still, the CT scan is the most readily available technology in most centers. The CT scan and magnetic resonance imaging also provide information on possible etiologies and can therefore direct the approach towards a tissue diagnosis.


Haigan ◽  
1987 ◽  
Vol 27 (1) ◽  
pp. 47-56
Author(s):  
Tetsuo Yamaguchi ◽  
Keiichi Nagao ◽  
Fumio Mizutani ◽  
Aya Hayashi ◽  
Takashi Sugita ◽  
...  

Author(s):  
S. Lowell Kahn

Superior vena cava syndrome (SVCS) comprises a constellation of symptoms resulting from stenosis, occlusion, or thrombosis of the SVC of benign and malignant etiologies. The diagnosis is most commonly seen with thoracic malignancies, with primary lung cancer accounting for up to 70% of cases. Up to 4% of lung cancer patients present with SVCS at the time of diagnosis, and many more develop it at a later time. In younger patients with SVCS, lymphoma is commonly responsible. Recently, there has been a rise in benign SVCS secondary to the increased use of central venous catheters and pacemakers. Endovascular stenting of the SVC for SVCS has been described for more than 25 years and is now the first-line treatment of choice for benign and malignant SVCS. This chapter describes the use of the Endologix AFX AAA system for the treatment of SVCS.


2016 ◽  
Vol 119 ◽  
pp. S667
Author(s):  
M.S. Mariaquila Santoro ◽  
M.L. Marianna Lacaria ◽  
M.A.M. Maria Angela Molinaro ◽  
L.R.F. Lucia Rachele Fabiano ◽  
A.D. Anna Destito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document